Director Declaration

RNS Number : 4868X

AstraZeneca PLC

16 February 2012

 



AstraZeneca PLC

Listing Rule LR 9.6.14 R (2)

David Brennan, Chief Executive Officer of AstraZeneca PLC, is to be appointed as a member of the Supervisory Board of Reed Elsevier NV and as a non-executive director of Reed Elsevier PLC with effect from 1 November 2012, subject to shareholder approval at the respective Reed Elsevier Annual General Meetings to be held on 24 and 25 April 2012.  He will also be appointed a non-executive director of Reed Elsevier Group plc.

A C N Kemp

Company Secretary

16 February 2012

 

END

 

 

RDNXELFFLLFEBBK